Utilizing Social Media and Mobile Health Data for Pharmacovigilance Service
New and innovative technologies, such as social media and mHealth (mobile health) technologies, have brought significant advancements to the field of pharmacovigilance. These technologies can be incorporated into pharmacovigilance services to enhance signal management and streamline Individual Case Safety Reports (ICSRs) processing and submission. However, certain challenges and considerations must be addressed to effectively harness the value of these technologies in supporting medicines regulation. Social media platforms offer unique advantages in pharmacovigilance and public health monitoring. They provide a vast volume of internet-based, patient-generated, unsolicited, continuously updated data. This abundance of data allows researchers to access a wide range of information for pharmacovigilance purposes. By analyzing social media content, including user's personal experiences with medications, potential adverse events related to specific drugs can be identified and monitored ...